F Delorme
Overview
Explore the profile of F Delorme including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giovannelli F, Mathieu C, Fritsch K, Adil K, Goutenoire F, Habicht K, et al.
Acta Crystallogr B Struct Sci Cryst Eng Mater
. 2020 Aug;
75(Pt 2):127-133.
PMID: 32830736
A new (NH)WO compound has been obtained by mixing WO and aqueous hydrazine solution at room temperature for 24 h. The reaction is catalyzed by the presence of lithium. X-ray,...
2.
Michel C, Jean M, Coulon S, Dictor M, Delorme F, Morin D, et al.
Appl Microbiol Biotechnol
. 2007 Sep;
77(2):457-67.
PMID: 17846760
The formation and activity of an As(III)-oxidising biofilm in a bioreactor, using pozzolana as bacterial growth support, was studied for the purpose of optimising fixed-bed bioreactors for bioremediation. After 60...
3.
Shirazi F, Bahrami G, Stewart D, Tomiak E, Delorme F, Noel D, et al.
J Pharm Biomed Anal
. 2001 May;
25(3-4):353-6.
PMID: 11377013
A rapid, simple and sensitive isocratic High Performance Liquid Chromatography (HPLC) method was developed to measure the concentration of etoposide in plasma samples with UV detection at 220 nm. The...
4.
Latreille J, Gelmon K, Hirsh V, Laberge F, Maksymiuk A, Shepherd F, et al.
Invest New Drugs
. 1999 Jun;
16(3):265-70.
PMID: 10360607
We performed a Phase II trial to evaluate the activity and tolerability of docetaxel as a single agent in the treatment of advanced non-small cell lung cancer (NSCLC). Forty-four patients...
5.
Rouini M, Lotfolahi A, Stewart D, Molepo J, Shirazi F, Vergniol J, et al.
J Pharm Biomed Anal
. 1998 Nov;
17(8):1243-7.
PMID: 9800643
A rapid, simple and sensitive isocratic high performance liquid chromatography (HPLC) method was developed to measure the concentration of docetaxel in plasma samples with UV detection at 227 nm. The...
6.
Libersan D, Khalil A, Dagenais P, Quan E, Delorme F, Uzan A, et al.
Cardiovasc Res
. 1998 Jul;
37(3):656-66.
PMID: 9659449
Objective: Heparin (HEP) is used in the post-thrombolytic state to prevent vessel reocclusion, thereby aiding myocardial salvage. Side effects limit its benefits, but besides anticoagulant activity HEP has diffuse actions...
7.
Nabholtz J, Smylie M, Mackey J, Noel D, Paterson A, Al-Tweigeri T, et al.
Oncology (Williston Park)
. 1997 Aug;
11(8 Suppl 8):37-41.
PMID: 9364541
Preliminary results from phase I trials suggest that the use of docetaxel (Taxotere) and doxorubicin (Adriamycin) is a well tolerated and highly active combination regimen for patients with metastatic breast...
8.
Urban P, Mignotte C, Kazmaier M, Delorme F, Pompon D
J Biol Chem
. 1997 Aug;
272(31):19176-86.
PMID: 9235908
Two NADPH-cytochrome P450 reductase-encoding cDNAs were isolated from an Arabidopsis cDNA library by metabolic interference in a Saccharomyces cerevisiae mutant disrupted for its endogenous cpr1 gene. ATR1 encodes a protein...
9.
Nabholtz J, Smylie M, Mackey J, Paterson A, Noel D, Janowska A, et al.
Oncology (Williston Park)
. 1997 Jun;
11(6 Suppl 6):25-7.
PMID: 9213324
A pilot phase II study examined the feasibility of 75 mg/m2 of docetaxel (Taxotere) in combination with 50 mg/m2 of doxorubicin and 500 mg/m2 of cyclophosphamide (Cytoxan, Neosar) in the...
10.
Leclerc J, Geerts W, Desjardins L, Laflamme G, LEsperance B, Demers C, et al.
Ann Intern Med
. 1996 Apr;
124(7):619-26.
PMID: 8607589
Objective: To compare the effectiveness and safety of fixed-dose enoxaparin and adjusted dose warfarin in preventing venous thromboembolism after knee arthroplasty. Design: A randomized, double-blind controlled trial. Setting: 8 university...